Eli Lilly's new pill orforglipron promises significant weight loss and improved heart health, challenging Novo Nordisk's offerings. With a potential price tag of $300, this small molecule drug could reshape the market by 2026.
Mar 26, 2026
Mar 26, 2026
Mar 26, 2026
Mar 26, 2026
Mar 26, 2026
Mar 26, 2026
Mar 26, 2026
Mar 26, 2026